{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:56:45Z","timestamp":1775869005320,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T00:00:00Z","timestamp":1367971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00408-013-9465-5","type":"journal-article","created":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T12:59:57Z","timestamp":1367931597000},"page":"379-383","source":"Crossref","is-referenced-by-count":21,"title":["The Impact of Neoadjuvant Chemotherapy on the Histopathological Assessment of Thymomas: A Clinicopathological Correlation of 28 Cases Treated with a Similar Regimen"],"prefix":"10.1007","volume":"191","author":[{"given":"Annikka","family":"Weissferdt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar A.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,8]]},"reference":[{"key":"9465_CR1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.hoc.2008.03.004","volume":"22","author":"LM Tormoehlen","year":"2008","unstructured":"Tormoehlen LM, Pascuzzi RM (2008) Thymoma, myasthenia gravis, and other paraneoplastic syndromes. Hematol Oncol Clin North Am 22:509\u2013526","journal-title":"Hematol Oncol Clin North Am"},{"key":"9465_CR2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1309\/AJCP76KEGWQKWOKA","volume":"137","author":"CA Moran","year":"2012","unstructured":"Moran CA, Weissferdt A, Kalhor N et al (2012) Thymoma I. A clinicopathologic correlation of 250 cases with emphasis on the World Health Organization Schema. Am J Clin Pathol 137:444\u2013450","journal-title":"Am J Clin Pathol"},{"key":"9465_CR3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1309\/AJCP36ALGUZWOSEA","volume":"137","author":"CA Moran","year":"2012","unstructured":"Moran CA, Walsh G, Suster S, Kaiser L (2012) Thymoma II. A clinicopathologic correlation of 250 cases with a proposed staging system with emphasis on pathologic assessment. Am J Clin Pathol 137:451\u2013461","journal-title":"Am J Clin Pathol"},{"key":"9465_CR4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2003.12.010","volume":"44","author":"ES Kim","year":"2004","unstructured":"Kim ES, Putnam JB, Komaki R et al (2004) Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation, therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 44:369\u2013379","journal-title":"Lung Cancer"},{"key":"9465_CR5","doi-asserted-by":"crossref","first-page":"S323","DOI":"10.1097\/JTO.0b013e3181f20e90","volume":"5","author":"GJ Ridley","year":"2010","unstructured":"Ridley GJ, Huang J (2010) Induction therapy for locally advanced thymoma. J Thorac Oncol 5:S323\u2013S326","journal-title":"J Thorac Oncol"},{"key":"9465_CR6","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0003-4975(03)01020-8","volume":"76","author":"F Venura","year":"2003","unstructured":"Venura F, Rendina EA, Longo F et al (2003) Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 76:1866\u20131872","journal-title":"Ann Thorac Surg"},{"key":"9465_CR7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.athoracsur.2007.08.051","volume":"85","author":"CD Wright","year":"2008","unstructured":"Wright CD, Choi NC, Wain JC et al (2008) Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors. Ann Thorac Surg 85:385\u2013389","journal-title":"Ann Thorac Surg"},{"key":"9465_CR8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/oxfordjournals.annonc.a058527","volume":"4","author":"A Berruti","year":"1993","unstructured":"Berruti A, Borasio P, Roncari A et al (1993) Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine, and cyclophosphamide (ADOC) in invasive thymomas: results in six patients. Ann Oncol 4:429\u2013431","journal-title":"Ann Oncol"},{"key":"9465_CR9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.coc.0000227481.36109.e7","volume":"29","author":"G Giaccone","year":"2006","unstructured":"Giaccone G, Wilmink H, Paul MA et al (2006) Systemic treatment of malignant thymoma: a decade experience at a single institution. Am J Clin Oncol 29:336\u2013344","journal-title":"Am J Clin Oncol"},{"key":"9465_CR10","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1200\/JCO.2010.32.9607","volume":"29","author":"GL Lemma","year":"2011","unstructured":"Lemma GL, Lee JW, Aisner SC et al (2011) Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol 29:2060\u20132065","journal-title":"J Clin Oncol"},{"key":"9465_CR11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/1097-0142(19910815)68:4<706::AID-CNCR2820680407>3.0.CO;2-H","volume":"68","author":"P Macchiarini","year":"1991","unstructured":"Macchiarini P, Chella A, Ducci F et al (1991) Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer 68:706\u2013713","journal-title":"Cancer"},{"key":"9465_CR12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.bjc.6605731","volume":"103","author":"H Kunitoh","year":"2010","unstructured":"Kunitoh H, Tamura T, Shibata T et al (2010) A phase II trial of dose-dense chemotherapy, followed by surgical resection and\/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606). Br J Cancer 103:6\u201311","journal-title":"Br J Cancer"},{"key":"9465_CR13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/01.coc.0000138963.01562.d3","volume":"28","author":"W Jacot","year":"2005","unstructured":"Jacot W, Quantin X, Valette S et al (2005) Multimodality treatment program in invasive thymic epithelial tumor. Am J Clin Oncol 28:5\u20137","journal-title":"Am J Clin Oncol"},{"key":"9465_CR14","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1510\/icvts.2010.255307","volume":"12","author":"E Belcher","year":"2011","unstructured":"Belcher E, Hardwick T, Lal R et al (2011) Induction chemotherapy, cytoreductive surgery and intraoperative hyperthermic pleural irrigation in patients with stage IVA thymoma. Interact Cardiovasc Thorac Surg 12:744\u2013748","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"9465_CR15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2003.09.022","volume":"44","author":"S Bretti","year":"2004","unstructured":"Bretti S, Berruti A, Loddo C et al (2004) Multimodal management of stage III\u2013IVA malignant thymoma. Lung Cancer 44:69\u201377","journal-title":"Lung Cancer"},{"key":"9465_CR16","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1517\/14656566.6.7.1169","volume":"6","author":"K Papadopoulos","year":"2005","unstructured":"Papadopoulos K, Thomas CR (2005) Current chemotherapy options for thymic epithelial neoplasms. Expert Opin Pharmacother 6:1169\u20131177","journal-title":"Expert Opin Pharmacother"},{"key":"9465_CR17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-5223(19)34092-9","volume":"106","author":"F Rea","year":"1993","unstructured":"Rea F, Sartori F, Loy M et al (1993) Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 106:543\u2013549","journal-title":"J Thorac Cardiovasc Surg"},{"key":"9465_CR18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/CCO.0b013e32834ea6bb","volume":"24","author":"L Spaggiari","year":"2012","unstructured":"Spaggiari L, Casiraghi M, Guarize J (2012) Multidisciplinary treatment of malignant thymoma. Curr Opin Oncol 24:117\u2013122","journal-title":"Curr Opin Oncol"},{"key":"9465_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11748-011-0814-0","volume":"60","author":"F Venuta","year":"2012","unstructured":"Venuta F, Rendina EA, Anile M et al (2012) Thymoma and thymic carcinoma. Gen Thorac Cardiovasc Surg 60:1\u201312","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"9465_CR20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/JTO.0b013e31802bafc8","volume":"2","author":"K Yokoi","year":"2007","unstructured":"Yokoi K, Matsuguma H, Nakahara R et al (2007) Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone. J Thorac Oncol 2:73\u201378","journal-title":"J Thorac Oncol"},{"key":"9465_CR21","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.athoracsur.2004.12.047","volume":"79","author":"M Lucchi","year":"2005","unstructured":"Lucchi M, Ambrogi MC, Duranti L et al (2005) Advanced stage thymomas and thymic carcinomas: results of multimodality treatments. Ann Thorac Surg 79:1840\u20131844","journal-title":"Ann Thorac Surg"},{"key":"9465_CR22","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ejcts.2010.11.026","volume":"39","author":"G Marulli","year":"2011","unstructured":"Marulli G, Lucchi M, Margaritora S et al (2011) Surgical treatment of stage III thymic tumors: a multi-institutional review from four Italian centers. Eur J Cardiothorac Surg 39:e1\u2013e7","journal-title":"Eur J Cardiothorac Surg"},{"key":"9465_CR23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.thorsurg.2010.08.003","volume":"21","author":"A Rajan","year":"2011","unstructured":"Rajan A, Giaccone G (2011) Chemotherapy for thymic tumors: induction, consolidation, palliation. Thorac Surg Clin 21:107\u2013114","journal-title":"Thorac Surg Clin"},{"key":"9465_CR24","volume-title":"Tumors of the thymus, Fascicle 13","author":"J Rosai","year":"1976","unstructured":"Rosai J, Levine GD (1976) Tumors of the thymus, Fascicle 13, vol 2. Armed Forces Institute of Pathology, Washington, DC"},{"key":"9465_CR25","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/00000478-200108000-00015","volume":"25","author":"CA Moran","year":"2001","unstructured":"Moran CA, Suster S (2001) Thymomas with prominent hemorrhagic and necrotic changes: a clinicopathologic study of 25 cases. Am J Surg Pathol 25:1086\u20131090","journal-title":"Am J Surg Pathol"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-013-9465-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-013-9465-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-013-9465-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T11:32:02Z","timestamp":1595763122000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-013-9465-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["9465"],"URL":"https:\/\/doi.org\/10.1007\/s00408-013-9465-5","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,8]]}}}